[Uterine leiomyoma].
Maruyama
Tetsuo
T
Department of Obstetrics and Gynecology, School of Medicine, Keio University.
Asada
Hironori
H
Ono
Masanori
M
Arase
Toru
T
Yoshimura
Yasunori
Y
D003613:Danazol / Q000627:therapeutic use; D003937:Diagnosis, Differential; D003952:Diagnostic Imaging; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists; D024003:HMGA Proteins / Q000235:genetics; D006801:Humans; D007044:Hysterectomy; D015907:Hysteroscopy; D007889:Leiomyoma / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D011379:Prognosis; D016212:Transforming Growth Factor beta / Q000502:physiology; D014594:Uterine Neoplasms / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy
D024003:HMGA Proteins; D016212:Transforming Growth Factor beta; D007987:Gonadotropin-Releasing Hormone; D003613:Danazol